Bicalutamide for Prostate Cancer
Bicalutamide (Casodex - Zeneca), an oral nonsteroidal antiandrogen similar to flutamide (Eulexin - Medical Letter, 31:72, 1989), is now available in the USA for treat-ment of advanced prostate cancer. The drug is recommended by the manufacturer for use concurrently with an analog of luteinizing hormone-releasing hormone (LHRH) such as leuprolide (Lupron; Lupron Depot) or goserelin (Zoladex -Medical Letter, 32:102, 1990)....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Bicalutamide for Prostate Cancer
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 977
Article Code: 977b
Date: June 21, 1996
Volume: 38
Pages: 56-57
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 977
Article Code: 977b
Date: June 21, 1996
Volume: 38
Pages: 56-57
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)